Drug and Environmental Factors Associated with Adverse Pregnancy Outcomes Part III: Folic Acid: Pharmacology,Therapeutic Recommendations,and Economics

Abstract

Spanish

French

OBJECTIVE:

To review folic acid's mechanism of action, adverse effects, therapeutic recommendations, compliance, and cost.

DATA SOURCES:

A MEDLINE search was conducted through December 1997. Additional sources were obtained from Current Contents and citations from the references obtained. Search terms included folate, folic acid, neural tube defect, homocysteine, and methylenetetrahydrofolate reductase.

STUDY SELECTION:

Animal and human studies examining the effects of folate were reviewed.

DATA EXTRACTION:

Data collected included mechanism of action, safety issues, dosing recommendations, compliance with recommendations, and economics.

DATA SYNTHESIS:

Folic acid decreases neural tube defect risk through an effect on methionine–homocysteine metabolism. In addition, increased folate intake may reduce cardiovascular morbidity and mortality. Since toxicity is minimal, everyone can potentially benefit from increased folate consumption. To help achieve this, the Food and Drug Administration has mandated that cereal grain be fortified with 140 μg of folic acid per 100 g of grain, which will add approximately 0.1 mg of folate to the average diet. Studies recommend supplementing with 0.2 mg to promote optimal homocysteine concentrations and for preventing neural tube defects.

CONCLUSIONS:

Despite fortification, most women will still receive less folate than the 0.4 mg/d recommended by the Public Health Service. All population groups would benefit from increased folate intake. Current studies indicate 200 μg/d may be the minimum effective amount of fortification needed for normalizing homocysteine concentrations and preventing a significant number of neural tube defects; thus, a higher level of food fortification may be warranted.

Keywords

pregnancy neural tube defects folate

Get full access to this article

View all access options for this article.

References

Lewis

Van Dyke

Stumbo

Berg

. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate. Ann Pharmacother 1998;32:802–17.

Lewis

Van Dyke

Stumbo

Berg

. Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid. Ann Pharmacother 1998;32:947–61.

Finkelstein

. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228–37.

Stipanuk

. Metabolism of sulfur-containing amino acids. Annu Rev Nutr 1986;6:179–209.

Ueland

Refsum

. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473–501.

Steegers-Theunissen

. Folate metabolism and neural tube defects: A review. Eur J Obstet Gynecol Reprod Biol 1995;61:39–48.

Mayer

Jacobsen

Robinson

. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517–27.

Steegers-Theunissen

RPM

Boers

GHJ

Trijbels

FJM

Finkelstein

Blom

Thomas

CMG

Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?

Metabolism 1994;43:1475–80.

Mills

McPartlin

Kirke

Lee

Conley

Weir

Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149–51.

10.

Steegers-Theunissen

Boers

Blom

Nijhuis

Thomas

CMG

Borm

Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 1995;172:1436–41.

11.

Steegers-Theunissen

RPM

Wathen

Eskes

TKAB

van Raaij-Selten

Chard

. Maternal and fetal levels of methionine and homocysteine in early human pregnancy. Br J Obstet Gynaecol 1997;104:20–4.

12.

Wouters

MGAJ

Boers

GHJ

Blom

Trijbels

FJM

Thomas

CMG

Borm

Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820–5.

13.

Goddijn-Wessel

TAW

Wouters

MGAJ

Molen

EFVD

Spuijbroek

MDEH

Steegers-Theunissen

RPM

Blom

Hyperhomocysteinemia: A risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:23–9.

14.

Rosenquist

Ratashak

Selhub

. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc Natl Acad Sci U S A 1996;93:15227–32.

15.

Eskes

TKAB

. Possible basis for primary prevention of birth defects with folic acid. Fetal Diagn Ther 1994;9:149–54.

16.

Bunduki

Dommergues

Zittoun

Marquet

Muller

Dumez

. Maternal—fetal folate status and neural tube defects: A case control study. Biol Neonate 1995;67:154–9.

17.

Ono

Sakamoto

Eguchi

Fujita

Nomura

Ueda

Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism 1997;46:959–62.

18.

Lucock

Wild

Schorah

Levene

Hartley

. The methylfolate axis in neural tube defects: In vitro characterisation and clinical investigation. Biochem Med Met Biol 1994;52:101–14.

19.

Whitehead

Gallagher

Mills

Kirke

Burke

Molloy

A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med 1995;88:763–6.

20.

Van der Put

NMJ

Steegers-Theunissen

RPM

Frosst

Trijbels

FJM

Eskes

TKAB

Van den Heuvel

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070–1.

21.

Lucock

Wild

Levene

. Enzyme defect as a risk factor for spina bifida (letter). Lancet 1995;346:1495–6.

22.

Stevenson

Brown

Schwartz

Allen

Khoury

Rapid publication: 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 1996;63:610–4.

23.

Van der Put

NMJ

Eskes

TKAB

Blom

. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM 1997;90:111–5.

24.

Harmon

Woodside

Yarnell

JWG

McMaster

Young

McCrum

The common “thermolabile” variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 1996;89:571–7.

25.

Jacques

Bostom

Williams

Ellison

Eckfeldt

Rosenberg

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7–9.

26.

Molloy

Daly

Mills

Kirke

Whitehead

Ramsbottom

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: Implications for folate intake recommendations. Lancet 1997;349:1591–3.

27.

Posey

Khoury

Mulinare

Adams

. Is mutated MTH-FR a risk factor for neural tube defects (letter)? Lancet 1996;347:686–7.

28.

Lucock

Wild

Lumb

Oliver

Kendall

Daskalakis

Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydro-folate: homocysteine methyltransferase. Biochem Mol Med 1997;61:28–40.

29.

Van der Put

NMJ

Van der Molen

Kluijtmans

LAJ

Heil

Trijbels

JMF

Eskes

TKAB

Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med 1997;90:511–7.

30.

Van der Put

NMJ

Thomas

CMG

Eskes

TKAB

Trijbels

FJM

Steegers-Theunissen

RPM

Mariman

ECM

Altered folate and vitamin B₁₂ metabolism in families with spina bifida offspring. Q J Med 1997;90: 505–10.

31.

Ramsbottom

Scott

Molloy

Weir

Kirke

Mills

Are common mutations of cystathionine β-synthase involved in the aetiology of neural tube defects?

Clin Genet 1997;51:39–42.

32.

Coelho

CND

Klein

. Methionine and neural tube closure in cultured rat embryos: Morphological and biochemical analyses. Teratology 1990;42:437–51.

33.

Coelho

CND

Weber

Klein

Daniels

Hoagland

. Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 1989;119:1716–25.

34.

Essien

Wannberg

. Methionine but not folinic acid or vitamin B₁₂ alters the frequency of neural tube defects in Axd mutant mice. J Nutr 1993;123:27–34.

35.

Nosel

Klein

. Methionine decreases the embryotoxicity of sodium valproate in the rat: In vivo and in vitro observations. Teratology 1992;46:499–507.

36.

Ehlers

Elmazar

MMA

Nau

. Methionine reduces the valproic acid-induced spina bifida rate in mice without altering valproic acid kinetics. J Nutr 1996;126:67–75.

37.

Wendel

Bremer

. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 1984;142:147–50.

38.

Ronge

Kjellman

. Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency. Arch Dis Child 1996;74:239–41.

39.

Allen

. Nutritional products. In: Covington

Lawson

Young

, eds. Handbook of nonprescription drugs, 10th ed. Washington, DC: American Pharmaceutical Association, 1993:283–311.

40.

Greene

NDE

Copp

. Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 1997;3:60–6.

41.

Reece

Khandelwal

Borenstein

. Dietary intake of myoinositol and neural tube defects in offspring of diabetic rats. Am J Obstet Gynecol 1997;176:536–9.

42.

Verhoef

Stampfer

. Prospective studies of homocysteine and cardiovascular disease. Nutr Rev 1995;53:283–8.

43.

Sutton-Tyrrell

Bostom

Selhub

Zeigler

. High homocysteine levels are independently related to isolated systolic hypertension in older adults (abstract). Circulation 1996;93:624.

44.

Den Heijer

Blom

Gerrits

WBJ

Rosendaal

Haak

Wijermans

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

Lancet 1995;345:882–5.

45.

Den Heijer

Koster

Blom

Bos

GMJ

Briet

Reitsma

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759–62.

46.

Neugebauer

Baba

Kurokawa

Watanabe

. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet 1997;349:473–4.

47.

Morrison

Schaubel

Desmeules

Wigle

. Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893–6.

48.

Tucker

Mahnken

Wilson

PWF

Jacques

Selhub

. Folic acid fortification of the food supply: Potential benefits and risks for the elderly population. JAMA 1996;276:1879–85.

49.

Boushey

Beresford

SAA

Omenn

Motulsky

. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049–57.

50.

Food and Drug Administration. Food labeling: Health claims and label statements; folate and neural tube defects. Fed Reg 1993;58(October 14):53254–95.

51.

Glynn

Albanes

. Folate and cancer: A review of the literature. Nutr Cancer 1994;22:101–19.

52.

Jennings

. Folic acid as a cancer-preventing agent. Med Hypotheses 1995;45:297–303.

53.

Crellin

Bottiglieri

Reynolds

. Folates and psychiatric disorders: Clinical potential. Drugs 1993;45:623–36.

54.

Ortega

Manas

Andres

Gaspar

Agudo

Jimenez

Functional and psychic deterioration in elderly people may be aggravated by folate deficiency. J Nutr 1996;126:1992–9.

55.

Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Reg 1996;61(March 5):8781–97.

56.

Campbell

NRC

. How safe are folic acid supplements? Arch Intern Med 1996;156:1638–44.

57.

Chanarin

Laidlaw

Loughridge

Mollin

. Megaloblastic anaemia due to phenobarbitone: The convulsant action of therapeutic doses of folic acid. Br Med J 1960;1:1099–102.

58.

Reynolds

. Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients. Lancet 1967;1:1086–8.

59.

Strauss

Bernstein

. Folic acid and Dilantin antagonism in pregnancy. Obstet Gynecol 1974;44:345–8.

60.

Ch'ien

Krumdieck

Scott

Butterworth

. Harmful effect of megadoses of vitamins: Electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics. Am J Clin Nutr 1975;28:51–8.

61.

Baylis

Crowley

Preece

Sylvester

Marks

. Influence of folic acid on blood—phenytoin levels. Lancet 1971;1:62–4.

62.

Mattson

Gallagher

Reynolds

Glass

. Folate therapy in epilepsy: A controlled study. Arch Neurol 1973;29:78–81.

63.

Norris

Pratt

. A controlled study of folic acid in epilepsy. Neurology 1971;21:659–64.

64.

Ralston

Snaith

Hinley

. Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants. Lancet 1970;1:867–8.

65.

Jensen

Olesen

. Subnormal serum folate due to anticonvulsive therapy: A double-blind study of the effect of folic acid treatment in patients with drug-induced subnormal serum folates. Arch Neurol 1970;22: 181–2.

66.

Gibberd

Nicholls

Wright

. The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol 1981;19:57–60.

67.

Backman

Holm

Hanstrom

Blomquist

Heijbel

Safstrom

. Folate treatment of diphenylhydantoin-induced gingival hyperplasia. Scand J Dent Res 1989;97:222–32.

68.

Brown

Di Stanislao

Beaver

Bottomley

. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia: A double-blind, randomized, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol 1991;71:565–8.

69.

Lewis

Van Dyke

Willhite

Stumbo

Berg

. Phenytoin—folic acid interaction. Ann Pharmacother 1995;29:726–35.

70.

Transcript of the Folic Acid Subcommittee. Department of Health and Human Services; Arlington, VA, November 23–24, 1992.

71.

Bower

Wald

. Vitamin B₁₂ deficiency and the fortification of food with folic acid. Eur J Clin Nutr 1995;49:787–93.

72.

Chanarin

. Adverse effects of increased dietary folate. Relation to measures to reduce the incidence of neural tube defects. Clin Invest Med 1994;17:244–52.

73.

Dickinson

. Does folic acid harm people with vitamin B₁₂ deficiency? Q J Med 1995;88:357–64.

74.

Stabler

. Screening the older population for cobalamin (vitamin B₁₂) deficiency. J Am Geriatr Soc 1995;43:1290–7.

75.

Carmel

. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097–100.

76.

Oakley

Adams

Dickinson

. More folic acid for everyone, now. J Nutr 1996;126(suppl):751S–5S.

77.

Hathcock

Troendle

. Oral cobalamin for treatment of pernicious anemia (editorial). JAMA 1991;265:96–7.

78.

Tamura

Goldenberg

. Zinc nutriture and pregnancy outcome. Nutr Res 1996;16:139–81.

79.

Tamura

Shane

Baer

King

Margen

Stokstad

ELR

. Absorption of mono- and polyglutamyl folates in zinc-depleted man. Am J Clin Nutr 1978;31:1984–7.

80.

Milne

Canfield

Mahalko

Sandstead

. Effect of oral folic acid supplements on zinc, copper, and iron absorption and excretion. Am J Clin Nutr 1984;39:535–9.

81.

Mukherjee

Sandstead

Ratnaparkhi

Johnson

Milne

Stelling

. Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy. Am J Clin Nutr 1984;40:496–507.

82.

Simmer

Iles

James

Thompson

RPH

. Are iron—folate supplements harmful? Am J Clin Nutr 1987;45:122–5.

83.

Keizer

Gibson

O'Connor

. Postpartum folic acid supplementation of adolescents: Impact on maternal folate and zinc status and milk composition. Am J Clin Nutr 1995;62:377–84.

84.

Ghishan

Said

Wilson

Murrell

Greene

. Intestinal transport of zinc and folic acid: A mutual inhibitory effect. Am J Clin Nutr 1986;43:258–62.

85.

Wolfe

Gibson

Gadowsky

O'Connor

. Zinc status of a group of pregnant adolescents at 36 weeks gestation living in southern Ontario. J Am Coll Nutr 1994;13:154–64.

86.

Keating

Wada

Stokstad

ELR

King

. Folic acid: Effect on zinc absorption in humans and in the rat. Am J Clin Nutr 1987;46:835–9.

87.

Butterworth

Hatch

Cole

Sauberlich

Tamura

Cornwell

Zinc concentration in plasma and erythrocytes of subjects receiving folic acid supplementation. Am J Clin Nutr 1988;47:484–6.

88.

Krebs

Hambidge

Hagerman

Peirce

Johnson

English

The effects of pharmacologic doses of folate on zinc absorption and zinc status (abstract). Am J Clin Nutr 1988;47:783.

89.

Tamura

Goldenberg

Freeberg

Cliver

Cutter

Hoffman

. Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome. Am J Clin Nutr 1992;56:365–70.

90.

Hambidge

Hackshaw

Wald

. Neural tube defects and serum zinc. Br J Obstet Gynaecol 1993;100:746–9.

91.

Kauwell

GPA

Bailey

Gregory

Bowling

Cousins

. Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects. J Nutr 1995;125:66–72.

92.

Bremert

Dreosti

Tulsi

. Teratogenic interaction of folic acid and zinc deficiencies in the rat. Nutr Rep Int 1989;39:383–90.

93.

Cornel

Erickson

. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 1997;55:134–7.

94.

Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41(no. RR-14):1–7.

95.

American College of Obstetricians and Gynecologists. Folic acid for the prevention of recurrent neural tube defects. Washington, DC, ACOG: 1993. Committee opinion 120.

96.

American Academy of Pediatrics Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1993;92:493–4.

97.

Forrest

. Preventing unintended pregnancy: The role of hormonal contraceptives. Epidemiology of unintended pregnancy and contraceptive use. Am J Obstet Gynecol 1994;170:1485–9.

98.

Delgado-Escueta

Janz

. Consensus guidelines: Preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42(suppl 5):149–60.

99.

Treiman

. Current treatment strategies in selected situations in epilepsy. Epilepsia 1993;34(suppl 5):S17–23.

100.

Epilepsy and pregnancy. Drug Ther Bull 1994;32:49–51.

101.

Sutcliffe

Schorah

Perry

Wild

. Prevention of neural tube defects (letter). Lancet 1993;342:1174.

102.

Wild

Sutcliffe

Schorah

Levene

. Prevention of neural-tube defects. Lancet 1997;350:30–1.

103.

Smith

Davies

. Prevention of neural tube defects (letter). Lancet 1994;343:123–4.

104.

Clark

NAC

Fisk

. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol 1994;101:709–10.

105.

Marsack

Alsop

Kurinczuk

Bower

. Pre-pregnancy counselling for the primary prevention of birth defects: Rubella vaccination and folate intake. Med J Aust 1995;162:403–6.

106.

De Jong-Van den Berg

LTW

Cornel

Tymstra

Buitendijk

. Folate prophylaxis in pregnancy (letter). Lancet 1995;346:1227–8.

107.

Doyle

. Folic acid in prevention of neural tube defects (letter). Lancet 1995;345:389–90.

108.

Centers for Disease Control and Prevention. Prevention program for reducing risk for neural tube defects — South Carolina, 1992–1994. MMWR Morb Mortal Wkly Rep 1995;44:141–2.

109.

Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age — United States, 1995. MMWR Morb Mortal Wkly Rep 1995;44:716–8.

110.

Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age — United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:721–3.

111.

Centers for Disease Control and Prevention. Knowledge about folic acid and use of multivitamins containing folic acid among reproductive-aged women — Georgia, 1995. MMWR Morb Mortal Wkly Rep 1996;45:793–5.

112.

Cuskelly

McNulty

Scott

. Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 1996;347:657–9.

113.

Shojania

. Folic acid and vitamin B₁₂ deficiency in pregnancy and in the neonatal period. Clin Perinatol 1984;11:433–59.

114.

Subar

Block

James

. Folate intake and food sources in the US population. Am J Clin Nutr 1989;50:508–16.

115.

Daly

Mills

Molloy

Conley

Lee

Kirke

Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666–9.

116.

Ward

McNulty

McPartlin

Strain

Weir

Scott

. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Q J Med 1997;90:519–24.

117.

Daly

Kirke

Molloy

Weir

Scott

. Folate levels and neural tube defects: Implications for prevention. JAMA 1995;274: 1698–702.

118.

McPartlin

Halligan

Scott

Darling

Weir

. Accelerated folate breakdown in pregnancy. Lancet 1993;341:148–9.

119.

Romano

Waitzman

Scheffler

. Folic acid fortification of grain: An economic analysis. Am J Public Health 1995;85:667–76.